• Home

  • Documents

  • Coronary Stents | Stent manufactures in India - Vascular · 2021. 5. 8. · eucaLimus Sirolimus...
2

Coronary Stents | Stent manufactures in India - Vascular · 2021. 5. 8. · eucaLimus Sirolimus Eluting Stent System Polymer PI-GA 85/15 80 90 100 110 . Provides consistent, controlled

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Coronary Stents | Stent manufactures in India - Vascular · 2021. 5. 8. · eucaLimus Sirolimus Eluting Stent System Polymer PI-GA 85/15 80 90 100 110 . Provides consistent, controlled
Page 2: Coronary Stents | Stent manufactures in India - Vascular · 2021. 5. 8. · eucaLimus Sirolimus Eluting Stent System Polymer PI-GA 85/15 80 90 100 110 . Provides consistent, controlled

Comparison of a Novel Biodegradable Polymer Everolimus-Eluting …doc.rero.ch/record/255876/files/coo_cnb.pdf · 2015-06-17 · polymer–based sirolimus-eluting Orsiro stent (O-SES)

Comparison of a Novel Biodegradable Polymer Everolimus-Eluting …doc.rero.ch/record/255876/files/coo_cnb.pdf · 2015-06-17 · polymer–based sirolimus-eluting Orsiro stent (O-SES)

Documents
AMPHILIMUS (SIROLIMUS+FATTY ACID) ELUTING … · Technical data Coronary stent Drug releasing formulation Product Catalogue • Polymer-free device • Drug releasing Abluminal reservoirs

AMPHILIMUS (SIROLIMUS+FATTY ACID) ELUTING … · Technical data Coronary stent Drug releasing formulation Product Catalogue • Polymer-free device • Drug releasing Abluminal reservoirs

Documents
Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent versus Sirolimus-Eluting Stent and PacliTaxel- Eluting Stent for Coronary Lesions: The

Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent versus Sirolimus-Eluting Stent and PacliTaxel- Eluting Stent for Coronary Lesions: The

Documents
ars.els-cdn.com · Web viewValues are shown as n (%). BP-BES, biodegradable polymer biolimus-eluting stent; BP-SES, biodegradable polymer sirolimus-eluting stent; CABG, coronary artery

ars.els-cdn.com · Web viewValues are shown as n (%). BP-BES, biodegradable polymer biolimus-eluting stent; BP-SES, biodegradable polymer sirolimus-eluting stent; CABG, coronary artery

Documents
YUKON Choice PC ® Sirolimus Eluting Coronary Stent System with a Biodegradable Polymer

YUKON Choice PC ® Sirolimus Eluting Coronary Stent System with a Biodegradable Polymer

Documents
MULTIcentre evaluation of Single high-dose bolus TiRofiban versus Abciximab with sirolimus eluting sTEnt or bare metal stent in acute myocardial infarction

MULTIcentre evaluation of Single high-dose bolus TiRofiban versus Abciximab with sirolimus eluting sTEnt or bare metal stent in acute myocardial infarction

Documents
LEADERS LEADERS A Prospective, Randomised, Non-Inferiority Trial Comparing Biolimus-Eluting Stent With Biodegradable Polymer Versus Sirolimus-Eluting Stent

LEADERS LEADERS A Prospective, Randomised, Non-Inferiority Trial Comparing Biolimus-Eluting Stent With Biodegradable Polymer Versus Sirolimus-Eluting Stent

Documents
Clinical Trial Results. org Evaluation by Optical Coherence Tomography (OCT) of Neointimal Coverage of Sirolimus-Eluting Stent Three Months After Implantation

Clinical Trial Results. org Evaluation by Optical Coherence Tomography (OCT) of Neointimal Coverage of Sirolimus-Eluting Stent Three Months After Implantation

Documents
Interventional Innovation I: Coronary Interventions and ......Study Title Sirolimus Eluting Angioplasty Balloon for In-Stent Restenosis, SABRE Study Design Prospective multi-center

Interventional Innovation I: Coronary Interventions and ......Study Title Sirolimus Eluting Angioplasty Balloon for In-Stent Restenosis, SABRE Study Design Prospective multi-center

Documents
IfU 10578986rev1 - MagResource · The CYPHER SELECT + Sirolimus-eluting Coronary Stent is indicated ... Use balloon purging technique described in the Operator’s Manual in Section

IfU 10578986rev1 - MagResource · The CYPHER SELECT + Sirolimus-eluting Coronary Stent is indicated ... Use balloon purging technique described in the Operator’s Manual in Section

Documents
Evolution of Novel BioMimeTM Sirolimus SirolimusEluting Stent … · 2011-05-13 · Sirolimus Total Drug Load (µg/mm22): *per mm 1.4 1.0 BioMime™ *10.0 1.0 1.25 MINIMIZING STRUT

Evolution of Novel BioMimeTM Sirolimus SirolimusEluting Stent … · 2011-05-13 · Sirolimus Total Drug Load (µg/mm22): *per mm 1.4 1.0 BioMime™ *10.0 1.0 1.25 MINIMIZING STRUT

Documents
A new polymer-free drug-eluting stent with nanocarriers eluting sirolimus from stent-plus-balloon compared with bare-metal stent and with biolimus A9 eluting stent in porcine coronary

A new polymer-free drug-eluting stent with nanocarriers eluting sirolimus from stent-plus-balloon compared with bare-metal stent and with biolimus A9 eluting stent in porcine coronary

Health & Medicine
Sirolimus Eluting CoCr Coronary Stent System …€¦ · Sirolimus Eluting CoCr Coronary Stent System Translumina – trust is what counts Yukon® Chrome PC 5-Years Randomized Clinical

Sirolimus Eluting CoCr Coronary Stent System …€¦ · Sirolimus Eluting CoCr Coronary Stent System Translumina – trust is what counts Yukon® Chrome PC 5-Years Randomized Clinical

Documents
Sirolimus ppt

Sirolimus ppt

Health & Medicine
2015-11-151 Biodegradable Polymer-Coated Sirolimus- Eluting Stent Implantation in AMI A Clinical and Angiographic Study General Hospital of Chinese People’s

2015-11-151 Biodegradable Polymer-Coated Sirolimus- Eluting Stent Implantation in AMI A Clinical and Angiographic Study General Hospital of Chinese People’s

Documents
CORONARY STENTS – EU ANALYSIS AND MARKET FORECASTS · (2014) Approval and launch of the STENTYS sirolimus-eluting, self-expanding stent in the EU ↑ (2015) Commercial launch of

CORONARY STENTS – EU ANALYSIS AND MARKET FORECASTS · (2014) Approval and launch of the STENTYS sirolimus-eluting, self-expanding stent in the EU ↑ (2015) Commercial launch of

Documents
A Case of Late Recurrent Vasospasm After Sirolimus-Eluting Stent … · 2009-02-04 · 176·Recurrent Vasospasm After DES eluting stent implantation. We suspect that the abnor-mal

A Case of Late Recurrent Vasospasm After Sirolimus-Eluting Stent … · 2009-02-04 · 176·Recurrent Vasospasm After DES eluting stent implantation. We suspect that the abnor-mal

Documents
Avaliação da segurança e eficácia do stent coronário de cromo-cobalto recoberto com sirolimus desenvolvido no Brasil Henrique B. Ribeiro, Campos CA, Lopes

Avaliação da segurança e eficácia do stent coronário de cromo-cobalto recoberto com sirolimus desenvolvido no Brasil Henrique B. Ribeiro, Campos CA, Lopes

Documents
BIOLIMUS-ELUTING STENT WITH BIODEGRADABLE POLYMER VERSUS SIROLIMUS-ELUTING STENT WITH DURABLE POLYMER: A RANDOMISED, NON-INFERIORITY TRIAL Stephan Windecker,

BIOLIMUS-ELUTING STENT WITH BIODEGRADABLE POLYMER VERSUS SIROLIMUS-ELUTING STENT WITH DURABLE POLYMER: A RANDOMISED, NON-INFERIORITY TRIAL Stephan Windecker,

Documents
endoprothèse coronaire (stent) enrobée de sirolimus ...€¦ · 02 HISTORIQUE DU REMBOURSEMENT Il s’agit de la première demande d’inscription sur la LPPR de l’endoprothèse

endoprothèse coronaire (stent) enrobée de sirolimus ...€¦ · 02 HISTORIQUE DU REMBOURSEMENT Il s’agit de la première demande d’inscription sur la LPPR de l’endoprothèse

Documents
Randomized Comparison of the Sirolimus Eluting Non ... · 1º Endpoint: Major Adverse Cardiac Events (Cardiac death, myocardial infarction, definite stent thrombosis, target vessel

Randomized Comparison of the Sirolimus Eluting Non ... · 1º Endpoint: Major Adverse Cardiac Events (Cardiac death, myocardial infarction, definite stent thrombosis, target vessel

Documents
UvA-DARE (Digital Academic Repository) Dual-therapy stent ... · The bio-engineered COMBO stent has a dual-therapy strategy, which combines a sirolimus eluting coating with an anti-CD34

UvA-DARE (Digital Academic Repository) Dual-therapy stent ... · The bio-engineered COMBO stent has a dual-therapy strategy, which combines a sirolimus eluting coating with an anti-CD34

Documents
Original Article - SciELO · 2007-05-30 · Table 1 - Baseline estimates of the decision analytic model: procedural phase for bare-metal stent (BMS) and sirolimus-eluting stent (SES)

Original Article - SciELO · 2007-05-30 · Table 1 - Baseline estimates of the decision analytic model: procedural phase for bare-metal stent (BMS) and sirolimus-eluting stent (SES)

Documents
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total

Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total

Documents
eucaLimus - EUCATECH · eucaLimus. Sirolimus Eluting Coronary Stent System. Ultrathin 65 µm Design. Excellent Deliverability. Degradable Polymermatrix. Synchronized Polymerdegradation

eucaLimus - EUCATECH · eucaLimus. Sirolimus Eluting Coronary Stent System. Ultrathin 65 µm Design. Excellent Deliverability. Degradable Polymermatrix. Synchronized Polymerdegradation

Documents
The Ultimaster Biodegradable-Polymer Sirolimus-Eluting ......or clinically-indicated target-lesion revascularization (TLR). Each component of TLF and stent thrombosis (ST), according

The Ultimaster Biodegradable-Polymer Sirolimus-Eluting ......or clinically-indicated target-lesion revascularization (TLR). Each component of TLF and stent thrombosis (ST), according

Documents
A Randomized Comparison of a Sirolimus-eluting Stent with Biodegradable Polymer versus an Everolimus-eluting Stent with a Durable Polymer for Percutaneous

A Randomized Comparison of a Sirolimus-eluting Stent with Biodegradable Polymer versus an Everolimus-eluting Stent with a Durable Polymer for Percutaneous

Documents
1 SIROLIMUS-ELUTING STENTS FOR IN-STENT RESTENOSIS TREATMENT IN 278 UNSELECTED PATIENTS: INSIGHTS ON LONG-TERM OUTCOMES FROM A LARGE TWO-CENTER REGISTRY

1 SIROLIMUS-ELUTING STENTS FOR IN-STENT RESTENOSIS TREATMENT IN 278 UNSELECTED PATIENTS: INSIGHTS ON LONG-TERM OUTCOMES FROM A LARGE TWO-CENTER REGISTRY

Documents
Shift of a General Idea with the Introduction of DESTCT, Oct 2002 Cardiovascular Research Foundation ANGIOPLASTY SUMMIT TLR vs. Stent Length SIRIUS : Sirolimus Eluting Stent % 10.2

Shift of a General Idea with the Introduction of DESTCT, Oct 2002 Cardiovascular Research Foundation ANGIOPLASTY SUMMIT TLR vs. Stent Length SIRIUS : Sirolimus Eluting Stent % 10.2

Documents
Supralimus™ bioabsorbable-polymer sirolimus-eluting stent ... M G 0 G 1 X The dosage of Sirolimus in the SupralimusDES is 1.4 µg per mm2 –total drug ... web-based registry to

Supralimus™ bioabsorbable-polymer sirolimus-eluting stent ... M G 0 G 1 X The dosage of Sirolimus in the SupralimusDES is 1.4 µg per mm2 –total drug ... web-based registry to

Documents